Oral cancer – including cancers of the mouth and throat – is an area that is attracting new attention from the diagnostic community – this time with the help of dentists. New, promising technologies are making it easier for dental and medical professionals to detect oral cancer earlier and to intervene before it is too late. Among the new generation of tests are the OncAlert oral cancer rapid point-of-care test strip test and the OraMark laboratory test by Vigilant Biosciences, Ft. Lauderdale, Fla, a leading innovator and developer of solutions that aid in the early detection of and intervention against cancer. “Both these tests are built on technology that measures biomarkers captured in an oral rinse, and they have been clinically validated to be associated specifically with mouth and throat cancer,” says Matthew H.J. Kim, founder, chairman and CEO of Vigilant Biosciences.